Introduction
C-CAM1, the rat homolog of human biliary glycoprotein I (BGPI), is a member of the carcinoembryonic antigen (CEA) family of Ig-like cell adhesion molecules (Cheung et al., 1993b; Culic et al., 1992) . In rat liver, C-CAM1, also known as L-form, is the longer of the two major splice variants that vary in the length of their cytoplasmic domains (71 versus 10 amino acids). The adhesive activity of C-CAM1 is well established with the ®rst immunoglobulin domain being essential for adhesion (Cheung et al., 1993a) . More recent evidence showing that the cytoplasmic domain of C-CAM1 is tyrosine phosphorylated by pp60 c-src in epithelial cells (Brummer et al., 1995) and p53-56 lyn in neutrophils (Skubitz et al., 1995) , is serine phosphorylated on Ser-503 (Najjar et al., 1995; Sippel et al., 1994) and binds the SHP-1 tyrosine phosphatase . This suggests that C-CAM1 may also play a role in signal transduction, the biological outcomes of which remain to be elucidated.
Our laboratory and other investigators have shown that the steady state levels of C-CAM RNA and protein in malignant cells (Becker et al., 1985; Faris et al., 1991; Hixson and McEntire, 1989; Hixson et al., 1985; Neumaier et al., 1993; Rosenberg et al., 1993) are frequently downregulated or absent (Thompson et al., 1990 (Thompson et al., , 1994 . For the mouse and human equivalents of C-CAM, Bgp and BGP, respectively, decreases in expression have been documented in colon, liver, breast and prostate carcinomas Luo et al., 1997; Neumaier et al., 1993; Rosenberg et al., 1993) . Downregulation has also been reported in rat preneoplastic hepatic nodules (DC Hixson, unpublished data) as well as dysplastic prostate glands , benign bladder dysfunction (Kleinerman et al., 1996) and colorectal adenomas in humans (Nollau et al., 1997) , all of which are classi®ed as premalignant lesions, suggesting that dysregulation of C-CAM is an early event in the carcinogenic process.
Recent studies have shown that C-CAM1 can suppress tumorigenicity of the human prostate carcinoma line, PC-3 , and mouse colonic carcinoma cell line, CT51 (Kunath et al., 1995) . However, little is known about the mechanism(s) whereby C-CAM1 elicits growth suppression. The adhesive activity of C-CAM is well-established and although the downstream eects of the adhesion event have yet to be clearly elucidated, available evidence suggests that C-CAM plays a role in the functional dierentiation of hepatocytes (Mowery and Hixson, 1991) as well as in the maintenance of the specialized apical membrane structure in luminal cells of the ventral prostate (Hsieh and Lin, 1994) . These observations in normal tissues suggest that in addition to its role in regulating cell growth, C-CAM1 may function in other processes involved in forming or maintaining histotypic associations. To this end, the studies reported here are aimed at identifying alterations in the morphology, histotypic organization and phenotype of C-CAM1 positive PC-3 cells in nude mouse tumors, aspects of C-CAM1 tumor suppression which have not been previously examined. Our results show that some cell lines that were initially growth inhibited by C-CAM1 regained their tumorigenic phenotype while maintaining expression of C-CAM1 and retaining growth inhibition in vitro. Moreover, these cell lines displayed more aggressive growth in vivo, suggesting that they may have acquired and/or lost expression of genes directly or indirectly involved in C-CAM1 mediated tumor suppression. Results from extensive studies of tumor nodules at the light and electron microscopic levels further demonstrate that expression of C-CAM1 decreases rather than enhances phenotypic dierentiation and that the ultrastructural and morphological changes induced by C-CAM1 occur independently of tumor suppression.
Results

Expression of C-CAM1 in human prostate carcinoma cells
PC-3 cells were infected with amphotropic retrovirus carrying the cDNA for C-CAM1. Following infection, G418 resistant clones isolated by ring and limiting dilution cloning were analysed for surface expression of C-CAM1 by¯uorescence-activated cell sorting (FACS) using polyclonal antibody (PAb) 669. The C-CAM1 positive cell populations from three clones designated PC3-2C, PC3-5C and PC3-11C, were enriched to 93 ± 97% by FACS and had levels of C-CAM expression at least 20-fold (up to 1000-fold) higher than background levels as detected in vector control (PC3-V) cells (Figure 1 ). In initial assays, PC3-5C and PC3-11C showed slightly lower levels of expression than PC3-2C ( Figure 1 ).
Suppression of tumorigenicity of PC-3 cells by C-CAM1 expression
The tumorigenic potential of the three C-CAM1 positive PC-3 lines, as well as that of the control PC3-V line, were tested in nude mouse assays under conditions similar to those of Hsieh et al. (1995) . In the ®rst four experiments, nude mice were injected subcutaneously with 1 ± 5610 6 C-CAM1 positive cells. Cells used in the ®rst three studies were isolated by a single FACS enrichment and expanded in vitro prior to injection. PC3-2C cells were sorted twice more by FACS (total of three sorts) to enrich for C-CAM1 positive cells prior to the fourth study. The combined tumor incidence data at the end points (5 ± 8 weeks) from these four separate studies are represented graphically in Figure 2 . As shown, the tumor incidence for control PC3-V cells was 73% (22/30). In contrast, the tumor incidence in mice injected with the three C-CAM1 positive PC-3 cell lines were 31% (PC3-5C), 45% (PC3-2C) and 48% (PC3-11C) lower. Cell lines possessing the suppression phenotype (sup+) in vivo were designated PC3-2Csup+, PC3-5Csup+ and PC3-11Csup+.
Reversion of the tumor suppression phenotype
In order to obtain tumor tissues for comparative morphologic and phenotypic analyses and to delineate more precisely when the growth of PC3-Vsup-cells diverged from that of the C-CAM1 positive sup+ cells, Figure 1 Expression of C-CAM in human prostate carcinoma PC-3 cells. C-CAM1 positive clones designated PC3-2C, PC3-5C and PC3-11C were analysed for surface C-CAM1 expression and tumorigenicity in study 1. PC3-V, a clonal line infected with the LNCX-7 retroviral vector lacking a C-CAM1 cDNA insert, was used as a C-CAM1 negative control for background¯uorescence in FACS assays and in tumorigenicity study 1. Cell lines were labeled for FACS analysis with PAb669 using the protocol described in Materials and methods
Figure 2
Assessment of the tumorigenic potential of C-CAM1 positive and negative PC-3 clones: studies 1 ± 4. Tumor growth was monitored from 3 ± 56 days post-injection and mice were sacri®ced and tumors measured at various time points up to 8 weeks. Tumors 44 mm 3 were considered to be incident. Data represents the combined tumor incidence at the end points (5 ± 8 weeks) of these four studies a ®fth study with larger numbers of mice was undertaken using PC3-2C, the cell line showing the highest level of growth suppression in vivo and in vitro in the initial four studies. Cultures established from a stock of PC3-2Csup+ cells frozen after study 4 were injected (3610 6 ) into the interscapular fat pad of male athymic nude mice. These cells had thus undergone an additional freeze/thaw cycle after storage for 16 weeks at 7808C. Unexpectedly, tumor incidence was nearly 100% (data not shown). Moreover, the volume of the PC3-2C tumor nodules was consistently greater than those formed by PC3-Vsup-cells (data not shown). To con®rm these results, another tumorigenicity assay (study 6) was performed with PC3-2C cultures established from a separate stock that had been sorted twice by FACS and stored for 36 weeks at 7808C. As was observed in study 5, tumor incidence was 100% (data not shown).
To ascertain whether the in vivo suppression of tumorigenicity was also lost by other C-CAM1 positive cell lines, a seventh tumorigenicity assay was performed. Since other subcutaneous tumor models have shown that tumor cells grow more readily at sites proximal to the head, due to a greater blood/nutrient supply in this region, the seventh study was also utilized to determine whether there were any site speci®c dierences in tumor growth among the PC-3 cell lines in our model system. In this study, nude mice were injected into the interscapular fat pad or subcutaneously into the right and left upper and lower¯anks with 2610 5 cells/site using cultured cells derived from frozen stocks of PC3-2C-1 cells (cells used in study 6), PC3-2C, PC3-5C and PC3-11C cells (cells used in studies 1, 2 and 3) and PC3-V cells. Prior to injection, these populations were analysed by FACS and all the C-CAM1 positive lines showed similar levels of expression that were 20 ± 100-fold higher than the PC3-V C-CAM negative cells ( Figure 3 ). As shown in Figure 4A , only PC3-11C cells showed signi®cant loss (480%) of tumorigenicity as measured by average tumor volume at all sites. In contrast, the other C-CAM1 positive lines grew more aggressively in vivo ( Figure 4A ) and showed equivalent or higher tumor incidence than the vector control ( Figure 4B ). Relative to the other cell lines, the PC3-5C cell line demonstrated an extended latency period lasting until day 21 ( Figure 4B ) which was followed by an extremely rapid period of growth resulting in tumors larger than those derived from the vector control ( Figure 4A ). Although the rates of growth varied at the three sites (fat pad4upper¯ank4lower¯ank) ( Figure 4A ), the dierences in the relative growth of the cell lines at each site was the same. Thus, PC3-11C was the only C-CAM1+ cell line that did not show reversion to a tumorigenic phenotype. The revertant C-CAM1 positive PC3 cells in study number 7 were designated PC3-2C-1sup-, PC3-2Csup-and PC3-5Csup-. The PC3-11C line which retained its tumor suppressive phenotype in vivo was designated PC3-11Csup+.
In vitro growth characteristics of C-CAM1 positive PC-3 cell lines
The eect of C-CAM1 expression on the growth rate of PC-3 cells in vitro was evaluated by determining the number of viable cells at various time points up to 72 h. Prior to the loss of tumor suppressor activity, PC3-2C and PC3-11C showed growth rates of 3 and 2 times lower, respectively than that of PC3-V ( Figure  5A ), results consistent with the ®ndings of Hsieh et al. (1995) and Kunath et al. (1995) . The growth rate for the PC3-5C line with the suppression phenotype was not determined. To determine if the C-CAM1 positive cell lines displaying the suppression phenotype in vivo were still growth suppressed in vitro relative to the PC3-V cell line, the growth rates of the ®ve cell lines used for tumorigenicity study 7 were assessed, as described previously. As shown in Figure 5B , all of the C-CAM1 positive cell lines showed at least a threefold reduction in growth rate compared to the C-CAM1 negative PC3-V cells. In vitro, C-CAM1 growth inhibition appeared to still be intact for PC3-2C-1, PC3-2C and PC3-5C despite the reversion of their suppressive phenotypes in vivo.
Morphological characteristics of suppressed C-CAM1 positive cell lines and tumorigenic revertants Sections of PC-3 nodules embedded in Spurr's were analysed at the light microscopic (1 mM thick sections) and ultrastructural (50 ± 80 nm thin sections) levels to identify changes in morphology, ultrastructure or histotypic interactions. C-CAM1 negative PC3-Vsuptumors were well-dierentiated and contained numerous glandular and cord-like arrays of cells surrounded by a well-organized stroma ( Figure 6A ). Tumors formed by C-CAM positive PC-3 cell lines, however, showed less histotypic organization and contained fewer glandular or cord-like structures and a more random in®ltration by the host stroma ( Figure 6B ± D) . Among the C-CAM1 positive tumors, PC3-5Csup-( Figure 6B ) demonstrated the highest degree of organization. While all of the C-CAM1 positive tumor nodules appeared to be well encapsulated, nodules formed by PC3-11Csup+ showed the most pronounced desmoplastic response (Roberts et al., 1986) that was manifested as a dense layer of connective tissue surrounding each small group of epithelial cells within the suppressed nodules ( Figure 6D ). Ultrastructural analysis con®rmed the lower degree of histological organization in the PC3-11Csup+ nodules relative to PC3-Vsup-. PC3-11Csup+nodules were composed of singly or poorly organized groups of cells with highly convoluted nuclei, prominent nucleoli, sparse, fragmented rough endoplasmic reticulum (RER), diminished golgi complexes, large desmosomes and few mitochondria ( Figure 6E and F). . Overall, C-CAM1 positive PC-3 nodules were less well organized, had fewer glandular structures and showed a more random in®ltration of stromal cells. In addition, PC-3 cells in the C-CAM1 positive nodules appeared larger in size than those in the C-CAM1 negative PC3-V nodules. Among the C-CAM1 positive lines, PC3-5Csup-(B) showed the highest degree of histotypic organization. Nodules formed by PC3-11Csup+ cells induced a signi®cant desmoplastic response that encapsulated the nodules in a thick layer of connective tissue. (E ± H), Electron micrographs from nodules formed by PC3-11Csup+ (E and F) and PC3-Vsup-(G and H) cells. Length of bars=2 mM. C-CAM1 positive PC3-11Csup+ nodules were composed of poorly organized groups of cells with highly convoluted nuceli (N), prominent nucleoli (Nu), sparse, fragmented rough endoplasmic reticulum (RER) (R), diminished golgi complexes (G), large desmosomes (D) and few mitochondria (M). Cells in C-CAM1 negative PC3-Vsup-nodules, in contrast, displayed a more complex ultrastructure composed of well-de®ned golgi complexes (G), large, well-formed mitochondria (M), rounded nuclei (N) and moderate amounts of RER (R)
Most of these characteristics were also shared by PC3-2C-1sup-cells (data not shown). In contrast, C-CAM1 negative PC3-V cells showed a more complex ultrastructure composed of well-de®ned golgi complexes, large, well-formed mitochondria, rounded nuclei and moderate amounts of RER ( Figure 6G and H).
As a means to quantify the dierences in nuclear and nucleolar morphology between C-CAM1 positive and negative tumor nodules, morphometric analysis was performed on 1 mM sections cut from plastic embedded nodules. No signi®cant dierences among the cell lines were observed for the nuclear major and minor axis or the axial pro®le ratios (data not shown). As shown in Figure 7 , there was a clear downward shift in the area to perimeter ratios for PC3-11Csup+ nuclei in comparison to PC3-V nuclei, a result consistent with the more convoluted shape of the PC3-11Csup+ nuclear envelopes. The nuclei in nodules formed by the other C-CAM1 positive cell lines, in contrast, did not show signi®cant shifts in the area to perimeter ratios relative to PC3-V (data not shown). Statistical analysis showed that the ratio of the mean area of the nuclei to the mean area of the nucleoli of the PC3-V cells was greater than the mean nuclear to nucleolar area ratios of all the C-CAM1 positive cell lines, results supporting the larger apparent size of the nucleoli in the C-CAM1 positive cell lines (Table 1) . Comparative analysis further showed that most of the SDs for the area and perimeter of nuclei and nucleoli among the C-CAM1 positive cell lines were signi®cantly greater than those of PC3-V cells (Table 1) , supporting visual observations suggesting a wider variation in the size of nucleoli and nuclei in C-CAM1 positive cell lines.
Expression of C-CAM1 in vivo and in vitro
Northern blot analyses, reverse transcription polymerase chain reaction (RT ± PCR) and indirect immunouorescence (IIF) analyses were used to examine the possibility that recovery of tumorigenicity by C-CAM1 positive cell lines resulted from loss of the C-CAM1 transgene, silencing of the retroviral promoter or from major rearrangements in the C-CAM1 transgene.
Results from Northern blot analyses on total RNA Figure 7 Frequency distribution of area to perimeter ratios for nuclei. There was a clear downward shift in the area to perimeter ratios (mM) of PC3-11Csup+ nuclei in comparison to PC3-Vsup-nuclei, quantitatively con®rming visual observations that PC3-11Csup+ nuclear envelopes are more convoluted than those of PC3-Vsup- No statistical analyses were completed on these values since data sets for nuclei and nucleoli were not matched C-CAM1 associated cellular changes in prostate cancer MM Comegys et al isolated from rat liver using a C-CAM-speci®c probe showed a predicted transcript size of 3.8 kb ( Figure 8 , lane 1). Analysis of total RNA from PC-3 cell lines in culture and from subcutaneous and fat pad tumor nodules showed that C-CAM message was undetectable in both the vector control cell line and in the corresponding PC3-V tumors ( Figure 8 , lanes 4 and 9 ± 12, respectively). As expected, two C-CAM transcripts, 6.0 kb and 2.6 kb, were detected in PC3-2C-1sup-, PC3-2Csup-, PC3-5C-1sup-and PC3-11Csup+ cell lines ( Figure 8 , lanes 5 ± 8) and corresponding tumor nodules ( Figure 8 , lanes 13 ± 35). Although two retroviral transcripts are made, C-CAM1 protein is only translated from the smaller 2.6 kb capped transcript that extends from the CMV promoter to the polyadenylation signal downstream of the C-CAM1 cDNA. Thus, levels of the 2.6 kb C-CAM1 transcript were normalized to both ethidium bromide staining of 18S ribosomal RNA and to levels of cytokeratin 8 (CK-8) (Figure 8 , transcript sizes= 2.4 kb, 1.7 kb and 1.1 kb), an epithelial marker that was used to control for the stromal (nude mouse derived) contribution to total tumor RNA. As shown in Table 2 , C-CAM1 message levels appeared to be equal to or slightly lower than that of cell lines in culture, a dierential that was detected irrespective of the suppression phenotype. IIF with PAb 669 on cryosections of tumor nodules showed that tumor cells in PC3-5Csup-( Figure 9B ), PC3-2C-1sup-(not shown), PC3-2C-sup-( Figure 9C ) and PC3-11Csup+ nodules ( Figure 9D ) were strongly positive for C-CAM compared to PC3-Vsup-( Figure 9A ) which was negative.
RT ± PCR analysis was performed using random hexamers for the reverse transcription and primer sets composed of a vector primer downstream of the 3' end of the C-CAM1 cDNA (VectorAS) and primers speci®c for the four extracellular Ig-like domains of C-CAM1, designated 5'UTR/Sig, D2S, D3S and D4S ( Figure 10A ). As shown in Figure 10B , ampli®cation of positive control C-CAM1 containing plasmid, LNCL, DNA with the four primer pairs produced products of the following sizes: (1) 5'UTR/Sig/VectorAS, 1650 bp (data not shown); (2) D2S/VectorAS, 1200 bp; (3) D3S/VectorAS, 780 bp and (4) D4S/VectorAS, 500 bp. As expected, ampli®cation of negative control (no insert) plasmid LNCX-7 DNA did not produce products with any of the primer pairs ( Figure 10B ). RT ± PCR with cell line RNA from all the C-CAM1 positive cell lines and with selected tumor RNAs generated bands of predicted sizes with primer pairs D2S/VectorAS, D3S/VectorAS and D4S/VectorAS ( Figure 10B ). Ampli®cation of the predicted 1650 bp product from the cell line or tumor RNA with primer pair 5'UTR/Sig/VectorAS was unsuccessful under a number of dierent RT ± PCR conditions. As an alternative approach for determining whether the ®rst extracellular domain of C-CAM1 was intact in our cell lines or tumors, RT ± PCR analysis was carried out with the 5'UTR/Sig primer described previously and a downstream primer in the second extracellular domain of C-CAM1, designated D2AS ( Figure 10A ). Control PCR on plasmid LNCL DNA generated a 485 bp product ( Figure 10C ). RT ± PCR of cell line or tumor RNA from all the C-CAM1 positive cell lines with the 5'UTR/Sig/D2AS primer pair generated bands of the Figure 8 Northern blot analysis of C-CAM1 and endogenous human BGPI in PC-3 cell lines in vivo and in vitro. Total RNA (15 mg) from each cell line (CL) or corresponding tumor nodules (T 1 ± T 5 ) was analysed by hybridization to a 218 bp C-CAM1 fragment (top row). Blots were then stripped and reprobed with a murine EndoA probe for cytokeratin 8 (second row) and a 220 bp probe speci®c for the 3'UTR of human BGPI (third row). Ethidium bromide staining served as a loading control (bottom row). Sizes of transcripts are indicated at the right. Lane 1: Sprague Dawley rat liver RNA (control for endogenous C-CAM1 transcripts); lane 2: Human prostate RNA (probable benign prostate hyperplasia) for C-CAM1 and CK-8 and human colon RNA for BGP I; lanes 3 ± 8: Cell line RNAs, (3) uninfected parent PC-3 cells, (4) PC3-V, (5) PC3-2C, (6) PC3-2C-1, (7) PC3-5C and (8) PC3-11C; lanes 9 ± 12 (T 1 ): RNA from PC3-V tumors: 9 ± 10,¯ank and 11 ± 12, fat pad tumors; lanes 13 ± 18 (T 2 ): RNA from PC3-2Csup-tumors: 13 ± 16,¯ank and 17 ± 18, fat pad tumors; lanes 19 ± 25 (T 3 ): RNA from PC3-2C-1sup-tumors: 19 ± 23,¯ank and 24 ± 25, fat pad; lanes 26 ± 33 (T 4 ): RNA from PC3-5Csup-tumors: 26 ± 31,¯ank and 32 ± 33, fat pad; lanes 34 and 35 (T 5 ): PC3-11Csup+ tumors: 34¯ank and 35 fat pad predicted 485 bp size ( Figure 10C ). In order to con®rm the integrity of the D1 domain, RE analysis of the 485 bp RT ± PCR products from cell line or tumor RNAs ( Figure 10C ) was performed with enzymes having recognition sequences in the D1 domains of various C-CAM isoforms. As shown in Figure 10C , digestion of ampli®ed products from cell line and tumor RNA with HincII, speci®c for C-CAM1 D1 domains, produced two bands of 350 bp and 135 bp. In contrast, DraI and XbaI, speci®c for the C-CAM2 D1 and the C-CAM4 D1 domains, respectively, were unable to digest the RT ± PCR products from any of the PC-3 cell line or tumor RNAs. Taken together, these RT ± PCR and RE results showed that there were no major rearrangements in C-CAM1 in any of the PC-3 cell lines in vitro or in vivo.
Eect of C-CAM1 on the expression of endogenous CAMs Hsieh et al. (1995) have previously reported that the parent PC-3 cell line is negative in vitro for human BGPI by both Northern and Western blot analyses. It was thus of interest to see if overexpression of C-CAM1 altered expression of BGPI was responsible for the suppression phenotype in the PC3-11C cell line, a question not previously addressed in prostate tumor models. Northern blot analyses using a human BGPI speci®c probe which detected transcripts in a human colon sample (3.5 kb) did not reveal the presence of transcripts in any of the cell lines in vitro or in nude mouse tumors (Figure 8 ), indicating that BGP1 expression was not altered by overexpression of rat C-CAM1 in the PC-3 cell lines.
E-cadherin is a cell adhesion molecule known to play an essential role in epithelial cell dierentiation and, like C-CAM, its expression is often decreased in tumors of epithelial origin (McNeill et al., 1990; Takeichi, 1991) . Restoration of expression is associated with diminished invasiveness and metastasis in a large variety of epithelial cancers (Foty and Steinberg, 1997; Mareel et al., 1992; Miyaki et al., 1995) . To determine whether dierences in E-cadherin expression contributed to the suppression and revertant tumorigenic phenotypes exhibited by the C-CAM1 positive PC-3 cell lines, IIF analyses using a polyclonal anti Ecadherin antibody were performed on cryosections from tumor nodules and on cultured cells. Results showed that greater than 90% of the cells in PC3-Vsup- (Figure 9E ), PC3-5Csup-( Figure 9F ), PC3-2C-1sup-(not shown), PC3-2Csup-( Figure 9G ) and PC3-11Csup+ ( Figure 9H ) tumor nodules were positive for E-cadherin. Similar levels of E-cadherin were observed in vitro by the ®ve PC-3 cell lines (data not shown). Overall, there was very little dierence in the levels of E-cadherin in C-CAM1 negative (PC3-V) and C-CAM1 positive cell lines with both suppression and revertant tumorigenic phenotypes.
Phenotypic changes associated with suppressed and tumorigenic C-CAM1 positive cell lines IIF analysis was performed to determine if changes in other phenotypic markers were associated with C-CAM1 expression and/or tumor suppression. Punctate desmoplakin I (DPI) staining patterns characteristic of Figure 9 Indirect immuno¯uorescence analysis of C-CAM1 and E-cadherin in PC-3 tumor nodules. Acetone ®xed cryosections of PC-3 tumor nodules were post-®xed in 2% paraformaldehyde, quenched with 1 M glycine and labeled with PAb669, speci®c for C-CAM (A ± D), and a polyclonal anti-E-cadherin antibody (E ± H). Length of bars=60 mM. (A) and (E) PC3-Vsup-nodules were negative for C-CAM and showed uniform and intense membrane staining with the anti-E-cadherin antibody. PC3-5Csup-(B and F), PC3-2Csup-(C and G) and PC3-11Csup+ (D and H) showed strong membrane staining for both C-CAM1 and E-cadherin, respectively In general, desmosomes in PC3-5Csup-( Figure 11B ), PC3-2C-1sup-(not shown), PC3-2Csup-( Figure 11C ) and PC3-11Csup+ ( Figure 11D ) tumors were more heterogeneous in size and less well-organized than those in PC3-Vsup-nodules ( Figure 11A ), a dierence also found at the ultrastructural level (data not shown).
Dierential staining of C-CAM1 positive and C-CAM1 negative tumor nodules were also observed using IIF with monoclonal antibody OV6 which recognizes an epitope shared by cytokeratins 14 and 19. PC3-V cells were intensely and uniformly stained by MAb OV6, particularly on the glandular and cordlike structures ( Figure 11E ) and cultures (data not shown). However, staining was markedly reduced and more heterogeneous in C-CAM1 positive nodules as represented by the staining of PC3-5Csup-shown in Figure 11F and cell lines (data not shown). IIF analysis with a large panel of antibodies against primary human prostate carcinoma cells identi®ed three epitopes/ antigens designated 2. 25.3, 12.3.3 and 14.33.7 , that were expressed in tumors formed by all four revertant Figure 10 RT ± PCR/Re analysis of C-CAM1 in cell lines in vitro and in vivo. RT ± PCR was performed on 1 mg of total RNA isolated from each of the cell lines (CL) and selected tumor samples (T). (A) Upstream primers, 5'UTR/Sig, D2, D3 and D4, used in combination with the downstream vector speci®c primer (VectorAS) were designed to sequentially amplify segments of the C-CAM1 cDNA containing all four D domains, 3D domains, 2D domains and 1D domain, respectively. (B) Analysis of D2, D3 and D4 domains. Lanes 1, 12 and 23: 100 bp DNA ladder, sizes of the brightest bands indicated at the left; Lanes 2, 13 and 24: No template controls for primer pairs D2/VectorAS, D3/VectorAS and D4/VectorAS, respectively. No product detected; Lanes 2, 14 and 25: PCR of retroviral plasmid LNCX-7, lacking a C-CAM1 cDNA insert, with primer pairs D2/VectorAS, D3/VectorAs and D4/ VectorAS, respectively. No product was detected; Lanes 4, 15 and 26: PCR of plasmid LNCL carrying the C-CAM1 cDNA with primer pairs D2/VectorAS, D3/VectorAS and D4/VectorAS, respectively. Product sizes are marked at the right; RNAs from cell lines PC3-2C, PC3-5C, PC3-11C, PC3-2C-1 and PC3-V ampli®ed with D2/VectorAS primer pair (lanes 5 ± 9 respectively) D3/ VectorAS primer pair (lanes 16 ± 20 respectively), D4/VectorAS primer pair (lanes 27 ± 31 respectively); PC3-V and PC3-2C-1 sup7 tumor RNAs ampli®ed with D2/VectorAS (lanes 10 and 11 respectively), D3/VectorAS (lanes 21 and 22 respectively) and D4/ VectorAS (lanes 32 and 33 respectively). (C) RT ± PCR analysis of D1 domains from cell line (CL 1 ± 4 ) and tumor (T) RNAs using 5'UTR/Sig/D2AS primer pair followed by RE analysis with DraI (D), HincII (H) and XbaI (X) speci®c for C-CAM1, C-CAM2 and C-CAM4 D1 domains, respectively. Undigested samples (U) appear adjacent to (left side) digested samples and product sizes are indicated on the right. Lane 1: 100 bp DNA ladder with sizes labeled on the left; Lanes 2 ± 5: Plasmid LNCL DNA; Lanes 6 ± 9: (CL 1 ) PC3-2C; Lanes 10 ± 13: (CL 2 ) PC3-5C; lanes 14 ± 17: (CL 3 ) PC3-11C; lanes 18 ± 21: (CL 4 ) PC3-2C-1; and lanes 22 ± 25: (T) PC3-2C-1sup-tumor tumorigenic cell lines but were absent in PC3-11Csup+ nodules (data not shown).
Northern blot analysis using a prostate speci®c antigen (PSA) probe that hybridized with a 1.4 kb transcript in normal human prostate total RNA did not detect signi®cant levels of this transcript in any of the cell lines in culture or in corresponding tumors (data not shown). Because of the large desmoplastic response in the C-CAM1 positive tumors, particularly the PC3-11Csup+ nodules, and the known role of TGF-b in mediating such a response (Roberts et al., 1986) and in regulating growth of normal prostate epithelium (Barrack, 1997; Culig et al., 1996; Perry et al., 1997) , levels of TGFb1, TGF-b2, TGF-b3, TGF-b receptor type I and TGF-b receptor type II were examined in vivo and in vitro to see if C-CAM1 expression was modulating this important growth regulatory pathway. As shown in Figure 12A , levels of TGF-b1 (transcript size=2.4 kb) and TGF-b3 (transcript size=3.8 kb) were very low in vitro for both the C-CAM1 positive and negative cell lines, while all the tumor nodules showed a consistent upregulation of these ligands. With the exception of PC3-5Csup-, the level of TGFb2 transcripts (transcript sizes=6.0, 4.9, 4.4 and 4.0 kb) were high in vitro for all the cell lines but were signi®cantly lower in all of the tumors nodules ( Figure 12A ). However, there were no major dierences in the level of expression of TGF-b2 between the C-CAM1 positive and C-CAM1 negative tumor nodules. Levels of type I (transcript size=5.0 kb) and type II (transcript sizes=5.5 kb) receptors were also similar in vitro and in vivo in both C-CAM1 positive and C-CAM1 negative cell lines ( Figure 12B ).
Discussion
The well-established adhesive activity of C-CAM1 and evidence that it plays a role in the functional dierentiation of hepatocytes (Mowery and Hixson, 1991) and maintenance of the apical membrane structure of the ventral prostate (Hsieh and Lin, 1994) suggest that C-CAM1 may not only regulate growth rate of epithelial cells but play a role in other processes such as the formation or maintenance of histotypic interactions. While recent studies have shown that C-CAM1 acts as a tumor suppressor protein in vivo Kunath et al., 1995) , the mechanism(s) whereby C-CAM1 elicits these eects remains largely unknown. To this end we have investigated how C-CAM1 alters the morphology, histotypic organization and phenotype of PC-3 cells, questions which have not been directly addressed in other C-CAM1 tumor suppressor model systems.
In our initial animal experiments, we observed suppression of tumorigenicity in three separate PC-3 cell lines (PC3-2C, PC3-5C and PC3-11C) transduced with retrovirus carrying the C-CAM1 cDNA, results similar to those obtained in studies by Hsieh et al. (1995) and Kunath et al. (1995) . In addition, this growth suppression in vitro correlated well with suppression of tumorigenicity (up to 80%) in vivo. However, in later studies (studies 5 and 6), the PC3-2C cell line, designated PC3-2C-1, not only lost its suppression phenotype in vivo but grew more rapidly and aggressively than the PC3-V line. When frozen stocks of PC3-2C, PC3-2C-1, PC3-5C and PC3-11C cell lines were retested for suppression (study 7), only the PC3-11C cell line retained the suppression phenotype. In addition, comparison of the growth rates of tumors at dierent sites (lower¯ank, upper¯ank and fat pad) showed that the growth rate varied depending on the site of injection for all of the cell lines with the highest rates of tumor growth in the upper¯ank and fat pad sites, a growth pattern most likely resulting from the increased blood supply near injection sites closer to the head. In spite of these dierences in growth, PC3-11C tumors were suppressed at all sites of injection, suggesting that C-CAM1 tumor suppression in this cell line was not aected by generally observed siterelated dierences in tumor growth. Since the morphological and phenotypic alterations associated with C-CAM1 expression, as discussed below, were essentially unchanged following loss of the suppression phenotype, it is unlikely that any of these alterations are responsible Figure 11 IIF analysis of frozen sections from C-CAM1 positive, suppressed and non-suppressed nodules. Acetone ®xed cryosections were labeled with MAbs speci®c for DPI (A ± D) and OV6 (E and F). Length of bars=125 mM. (A) Desmosomes (punctatē uorescence) in PC3-Vsup-nodules were more well-organized and homogeneous in size than PC3-5Csup-(B), PC3-2Csup-(C) and PC3-11Csup+ cells. The larger size of the cells in C-CAM1 positive nodules (B ± D) relative to C-CAM1 negative controls (A) was evidenced by the dierences in the size of cell outlines de®ned by desmosomes. When compared to PC3-Vsup-nodules (E), OV6 staining was markedly reduced and more heterogeneous in C-CAM1 positive nodules, represented here by a PC3-5Csup-nodule (F) for the recovery of tumorigenicity PC3-2C, PC3-2C-1 and PC3-5C cells. This suggests that C-CAM1 growth suppression in these cell lines created a strong selection for C-CAM1 positive cells that had spontaneously gained or lost the expression of presently unknown negative and positive eectors in signal pathways needed for tumor suppression.
In spite of the loss of growth suppression in vivo, all the C-CAM1 positive, tumorigenic cell lines as well as PC3-11Csup+ cells continued to grow 2 ± 3 times slower than the PC3-V cell line in vitro. Thus, C-CAM1 inhibition of growth in vitro did not correlate with tumor suppression in vivo, suggesting that loss of the suppression phenotype was an in vivo phenomenon resulting from matrix in¯uences or angiogenesis or other factors not present in vitro. The suppression phenotype initially displayed by all the C-CAM1 positive cell lines argues that the PC3-11C line was not a clonal population possessing a low level of tumorigenicity prior to C-CAM1 expression. Variation Figure 12 Northern blot analysis of TGF-b ligands and type I and II receptors in vivo and in vitro. Total RNA (15 mg) from each cell line (CL) and selected corresponding tumor nodules (T 1 ± 5 ) was analysed by sequential hybridization to (A) a 900 bp fragment of rat TGF-b1 (®rst row), a 1.2 kb fragment of simian TGF-b2 (second row) and a 1.2 kb fragment of TGF-b3 (third row) or (B) a 1.6 kb fragment of human TGF-b type I receptor (®rst row) and a 1.7 kb fragment of human TGF-b type II receptor (second row). Ethidium bromide staining served as a loading control in both (A) and (B) (bottom row). Sizes of transcripts are indicated at the right. Lane 1: Sprague Dawley rat liver RNA; lane 2: RNA from human prostate (probable benign prostate hyperplasia); lanes 3 ± 8: cell line RNAs, (3) uninfected parent PC-3 cells, (4) PC3-V, (5) PC3-2C, (6) PC3-2C-1, (7) PC3-5C and (8) PC3-11C; lanes 9 and 10 (T 1 ): PC3-Vsup-nodules; lanes 11 and 12 (T 2 ): PC3-2Csup-nodules; lanes 13 and 14 (T 3 ): PC3-2C-1sup-nodules; lanes 15 and 16 (T 4 ): PC3-5Csup-nodules; lanes 17 and 18 (T 5 ): PC3-11Csup+ nodules C-CAM1 associated cellular changes in prostate cancer MM Comegys et al in the stability of the suppression phenotype among the C-CAM1 positive PC3 cell lines may instead be due to dierences in chromosomal integrity or retroviral integration sites among these clones. Taken together, our in vitro and in vivo growth studies suggest that other molecules are essential for establishing the C-CAM1 associated tumor-inhibitory phenotype in vivo.
RT ± PCR/RE, Northern blot and IIF analyses with C-CAM speci®c antibodies did not reveal any major rearrangements or truncations in the C-CAM1 cDNA that could account for the recovery of tumorigenicity by PC3-2C-1sup-, PC3-2Csup-and PC3-5Csup-cells. Turbide et al. (1997) recently reported that clones of CT51 mouse colonic tumor cells expressing levels of BgpL (C-CAM1) 2 ± 4-fold over background were suppressed in vivo while those with levels from 11 ± 25-fold over background were not, suggesting that physiological levels' of C-CAM1 are essential for the tumor suppressor activity . In contrast, data from both our early and later studies demonstrated that PC-3 cell lines expressing levels of C-CAM1 20 ± 100-fold over background displayed suppression phenotypes in vivo. Moreover, both suppressed and non-suppressed cell lines expressed similar levels of C-CAM1 both in vivo and in vitro, suggesting that in our model system`overexpression' (i.e. levels higher than tenfold over background) of C-CAM1 did not play a role in the abrogation of tumor suppression. Based on results from our studies and those of Turbide et al. (1997) , we propose as an alternative hypothesis that high levels of C-CAM1 expression result in a selective disadvantage during reconstitution/recovery in vitro or in vivo that compromises/delays the re-establishment of suppressed cells relative to tumorigenic revertants, the outcome being a shift to a predominantly suppression negative phenotype. Once cultures or injected cells stabilize, the growth advantage provided by the revertant tumorigenic phenotype decreases as suggested by the similar growth rates of suppressed and non-suppressed cell lines in vitro. Low levels of C-CAM1 within the physiological range de®ned by Turbide et al. (1997) , in contrast, create a much smaller dierential in survival during reconstitution or latency in vivo, the result being cultures or nodules that are composed largely of cells with the suppression phenotype.
Changes in the expression of other endogenous growth regulatory CAMs such as BGPI (the human C-CAM1 homolog) and E-cadherin, did not correlate with reversion to the tumorigenic phenotype in our C-CAM1 positive PC3 cell lines. However, C-CAM1 expression was accompanied by changes in the expression of other non-CAM related, MAb-de®ned epitopes, changes which may relate directly or indirectly to the adhesive or other signal transducing activities of C-CAM1 Brummer et al., 1995; Najjar et al., 1995; Sippel et al., 1994; Skubitz et al., 1995) . This possibility was exempli®ed by the C-CAM1 associated decrease in OV6, an epitope shared by CK14 and CK19, members of a large family of cytoskeletal intermediate ®lament proteins that play important roles in the maintenance of intracellular organization as well as cell integrity and shape (Goldman et al., 1990; Green and Jones, 1990; Lazarides, 1980; Marceau and Loranger, 1995; Omary and Ku, 1997) . The OV6 epitope was expressed at high levels on the duct and cord-like structures in the PC3-V tumor nodules but was displayed heterogeneously by the poorly organized C-CAM1 positive nodules. This preferential distribution in duct-like structures was consistent with a recent report showing high levels of CK19 on ducts and high but more heterogeneous levels on alveoli in human prostate (Yang et al., 1997) , a distribution also found in rat prostate (S-H Lin and A Makarovskiy, unpublished data).
An enhanced desmoplastic response was observed in thick sections of C-CAM1 positive tumor nodules, particularly nodules of PC3-11Csup+ cells, suggesting that the growth of these tumors was at least partially dampened by the formation of a thick, host-derived connective tissue wall. Desmoplastic responses in tumors are often associated with oversecretion of TGF-b, a growth factor which in vivo stimulates recruitment and proliferation of stromal cells and inhibits the growth of epithelial cells, or with increased sensitivity to this growth factor (Lieberman and Lebovitz, 1990; Roberts et al., 1986) . Thus, the presence of a pronounced desmoplastic response in nodules of PC3-11Csup+ cells raised the possibility that the suppression phenotype was associated with an increase in TGF-b or its receptors. However, no signi®cant up or downregulation of TGF-b ligands 1, 2 or 3 or TGF-b receptor type I or type II was observed in C-CAM1 positive nodules relative to tumors formed by PC3-V cells, indicating that this receptor signaling pathway was probably not involved in C-CAM1 associated desmoplastic response or in C-CAM1 mediated tumor suppression.
In addition to the associated changes in the expression of MAb-de®ned epitopes, C-CAM1 had striking eects on the interaction of PC-3 cells in vivo. Previous studies in myoblast culture systems (Rojas et al., 1996) and studies of C-CAM expression during liver development (Cheung et al., 1993b; Mowery and Hixson, 1991; Thompson et al., 1993) have shown that C-CAM (or BGP) accelerates dierentiation of myoblasts in vitro and is associated with the functional dierentiation of hepatocytes in the developing liver, respectively. However, C-CAM1 expression appeared to induce a less organized or dierentiated state in the PC-3 nude mouse tumors, evidenced by the decrease in number or absence or glandular/ductular and cord-like structures found in control PC3-V tumors. C-CAM1 also appeared to in¯uence the distribution of nude mouse-derived stroma in these tumors, evident in the higher degree of stromal organization in PC3-V tumors relative to their C-CAM1 positive counterparts. Taken together these results suggest that the suppression phenotype is not directly related to dierentiation status of the tumor cells.
Light and electron microscopic examination of nude mouse tumors also showed that C-CAM1 expression was closely associated with distinct changes in ultrastructural complexity as well as nuclear and nucleolar morphology in nodules from both tumorigenic and growth suppressed cell lines. At the ultrastructural level, C-CAM1 expression in both suppressed and non-suppressed lines correlated with a diminished cytoplasmic complexity, a change that was paralleled by decreased levels of histotypic organization and changes in cellular interactions as evidenced by the more random distribution as well as the increased heterogeneity in size of desmosomes. Both visual and morphometric analysis indicated that all the C-CAM1 positive cell lines had larger nucleoli than their PC3-V counterparts. Nucleolar enlargement is indicative of cells which are producing large amounts of proteins and suggests that C-CAM1 may be upregulating synthesis of other proteins, a possibility seemingly at odds with the diminished cytoplasmic complexity and the decrease in some phenotypic markers and the lack of change in others. However, prostatic epithelial cells normally secrete a number of dierent proteins in addition to PSA (mucopolysaccharides and enzymes) one or more of which could have been upregulated following C-CAM1 expression. C-CAM1 expression was also associated with changes in nuclear envelope morphology. C-CAM1 positive cells in tumor nodules were signi®cantly more convoluted than those of C-CAM1 negative PC3-V tumors, a subjective observation supported by a downward shift in area to perimeter ratios calculated from comparative morphometric analysis of PC3-11Csup+ versus PC3-Vsupnodules. Whether this shift re¯ects a distinction related to the suppression phenotype is a question that will require the analysis of a much larger collection of C-CAM1 positive, tumorigenic and growth-inhibited cell lines. Taken together, these results suggest that the ultrastructural and morphological changes induced by C-CAM1 occur independently of tumor suppression.
In summary, our results show that restoration of C-CAM1 expression in PC3 cells produces a decrease in vivo in histological organization, alterations in the expression of several phenotypic markers and changes in nuclear morphology. This was contrary to previous in situ results that implicated a role for C-CAM in membrane dierentiation and bile canalicular morphogenesis. These dierences suggest that expression of C-CAM1 alone may produce changes distinct from those observed in situ or in vitro with cells expressing both the short (C-CAM2) and long (C-CAM1) isoforms. Our ®ndings also demonstrate that phenotypic and morphological changes occur independently of the tumor suppression phenotype induced by C-CAM1. Taken together, our results raise the possibility that the adhesive N-terminal IgV-like domain and the cytoplasmic suppressor domain may activate separate signaling pathways. The N-terminal domain together with the short isoform may act to modulate the growth regulating activity of the C-CAM1 cytoplasmic domain and in addition, may lead to other end points attributed to C-CAM such as ATPase or bile transport activity. Finally, our results show that the loss of the suppression phenotype is not caused by the loss of C-CAM1 and does not correlate with signi®cant changes in any of the known markers examined, suggesting that the growth inhibiting activity of C-CAM1 may pose a strong selection for cells that escape suppression by undergoing as yet unidenti®ed changes in signal pathways required for the suppression phenotype.
Materials and methods
Plasmid construction and production of retrovirus
The C-CAM1 expression vector was constructed from the LNCX retroviral vector of AD Miller et al. (Miller and Buttimore, 1986; Miller et al., 1992) , carrying the neo gene which confers resistance to geneticin (G418) and three unique restriction sites for insertion of genes of interest downstream from the CMV promoter. To facilitate subcloning of the C-CAM1 cDNA, we inserted a 38 bp adapter into the multiple cloning site which carried recognition sequences for seven restriction enzymes (RE) (HindIII, EcoRI, SalI, XhoI, NsiI, NotI and ClaI). This modi®ed vector was designated LNCX-7. A cDNA insert (approximately 1.8 kb) containing the entire C-CAM1 coding sequence was cut from a pCDM8 construct obtained from Dr Sue-Hwa Lin with HindIII and NotI and subcloned into LNCX-7. This new construct containing the C-CAM1 cDNA was designated LNCL, L for long form. In order to obtain high titer viral supernatants, a two-step protocol for virus production was used. First the ecotropic packaging cell line BOSC23 (Pear et al., 1993) , grown in Dulbecco's MEM high glucose (Gibco/BRL, Gaithersburg, MD, USA) containing 10% fetal bovine serum, was transfected with 6 mg LNCL or LNCX-7 (no insert) plasmid DNA mixed in 26 ml Lipofectamine (Gibco/ BRL, Gaithersburg, MD, USA) for 5 h at 378C. Ecotropic retroviral supernatants were collected at 18 ± 24 h intervals from transfected BOSC23 cells grown to 90% con¯uency. These ecotropic supernatants were then used to infect the amphotropic packaging cell line PA317 (Miller and Buttimore, 1986) . PA317 cells at approximately 30% con¯uency were incubated in the presence of 4 ml/ml polybrene and 3 ml ecotropic virus for 18 h at 378C. At 48 h post-infection, PA317 cells were split 1 : 10 and cultured in the presence of 500 mg/ml G418 for 14 days. Resistant colonies were pooled and virus was collected as already described for the BOSC23 packaging line.
Retroviral infection of PC-3 cells and selection of C-CAM1 positive clones
PC-3 cells were infected as described above with amphotropic virus carrying the LNCL or the empty LNCX-7 vector. At 48 h post-infection, the PC-3 cells were split and cultured in the presence of 500 mg/ml G418 in RPMI 1640 (Gibco/BRL, Gaithersburg, MD, USA) supplemented with 5% Rehatuin fetal bovine serum (Intergen, Purchase, NY, USA) for 14 days and ring-cloned drug resistant colonies were further cloned by limiting dilution. Single cell clones infected with LNCL virus were initially screened for expression of C-CAM1 by indirect immuno¯uorescence (IIF) with polyclonal antibody (PAb) 669 speci®c for C-CAM (Lin and Guidotti, 1989) . Three clones showing a high percentage of C-CAM1 positive cells (490%) by IIF were further analysed by cyto¯uorometry.
FACS analyses
Suspensions of each of the three PC-3 clones (1610 7 cells) that were positive in the initial screen by IIF were labeled in suspension with a 1 : 200 dilution of primary antibody PAb 669 in culture media by rotating cells end over end for 20 min at 48C. After incubation with PAb 669, cells were washed twice with cold media. Cells were then incubated with a 1 : 100 dilution of goat anti-rabbit FITC conjugated secondary antibody (Cappel/Organon Teknika, Durham, NC, USA) as they were for the primary antibody labeling. Labeled cells were washed twice with cold PBS supplemented with 0.1% BSA, resuspended at 1610 7 cells/ml in PBS and were analysed by¯ow cytometry in the Central Research Laboratories at Rhode Island Hospital. Flow cytometry was performed on a BD FACSort apparatus (Becton Dickinson, San Jose, CA, USA) equipped with a 488 nm argon laser with 15 mW of power. Granularity and size were determined on the basis of forward (FSC) and side (SSC) scatter using a scale of 256 arbitrary units. Fluorescence was measured on a logarithmic scale using a band pass ®lter for FITC. Cells were considered positive if they displayed a¯uorescence intensity greater than that exhibited by 93% of the control clone infected with the LNCX-7 virus labeled with both the primary and secondary antibody. The¯ow cytometer was sterilized by running it for 30 min with 30% bleach followed by sterile sheath¯uid prior to use if the cells were to be collected for further culturing. Approximately 10 000 events (cells) were counted for simple analyses and approximately 100 000 events were collected via drop delay into BSA coated tubes containing 5 ml of culture media to obtain C-CAM1 enriched populations from clones that had at least 20-fold higher peak¯uorescence level than that of the negative control.
In vitro growth assay
The in vitro growth rates of C-CAM1-transduced PC-3 clones were estimated from the increase in number of cells with time in culture. Cells were cultured in RPMI 1640 (Gibco/BRL, Gaithersburg, MD, USA) supplemented with 5% Rehatuin fetal bovine serum (Intergen, Purchase, NY, USA), trypsinized from tissue culture dishes at 6 ± 12 h intervals up to 72 h, diluted in 0.2% trypan blue and counted on a hemocytometer. Results represent average viable cell counts from either two or three separate culture dishes for each time point investigated.
Assessment of in vivo tumorigenicity, tumor measurements and tissue procurement
To evaluate the tumorigenic potential of each PC-3 clone, 1 ± 5610 6 cells/site were injected into 1 ± 4 sites (subcutaneously into the right and/or left upper and lower¯anks or into the interscapular fat pad) of 6 ± 8-week-old male athymic nude mice. At 24 ± 48 h prior to injection of the tumor cells, mice were dosed intraperitoneally with two antibodies, anti-Lyt 2.2 (American Type Culture Collection, Rockville, MD, USA) (Sarmiento et al., 1980; and rabbit anti-asialo GM1 (Wako, Richmond, VA, USA) (Beck et al., 1982; Stitz et al., 1986) , to block any anti-tumor responses from peripheral CD8 positive T cells (Kung, 1988; Lake et al., 1991; Leo et al., 1988) or natural killer cells (Budzynski and Radzikowski, 1994) , respectively, that have been shown to exist in these immune de®cient mice. In the ®rst six studies, tumor growth was monitored from 3 ± 56 days post-injection and mice were sacri®ced at various time points up to 8 weeks. In study 7, tumors were monitored starting at 14 days post-injection and mice were not sacri®ced until the end of the experiment at 34 days post-injection. The dimensions of palpable tumors were measured with calipers. Tumor volume was calculated as described by Hsieh et al. (1995) using the formula volume=length6width6height60.5236. Tumor nodules excised from mice euthanized by CO 2 asphyxiation were weighed and processed as follows: (1) for RNA isolation tumors were snap frozen in liquid nitrogen; (2) for cryosectioning tumors were embedded in OCT and frozen in a dry ice/hexane bath as previously described (Faris et al., 1991) and (3) for preparation of thick and thin plastic sections, tumors were ®xed in 2% paraformaldehyde and 0.1% gluteraldehyde.
Reverse transcription-polymerase chain reaction (RT ± PCR) and restriction enzyme (RE) analysis RT ± PCR was performed using 1 mg total RNA and the GeneAmp RNA PCR kit (Perkin Elmer/Cetus, Norwalk, CT, USA) with the exception of the Taq Polymerase which was purchased from Promega (Madison, WI, USA) according to the manufacturer's directions. The following forward C-CAM primers were used: (1) 5'UTR/Sig 5'-CAGGCAGCAGA-GACTATGGAGCTA-3' (nucleotides 14 ± 9); (2) D2 5'-GTCACAGGTAACAACTCCAATCCC-3'
(nucleotides 445 ± 468); (3) D3 5'-CAACATCACTACTAACAA-TAGCGG-3' (nucleotides 861 ± 884) and (4) D4 5'-TCA-GAATAGACCCTATTAAGAGAGA-3' (nucleotides 1130 ± 1154). Each of these 5' primers was paired in a separate reaction with the following reverse vector (LNCX-7) speci®c primer: 5'-ATTTTATCGATGCGGCCGCGA-3'. For additional analysis of the 5' end of C-CAM1 including the D1 domain, the following set of primers was also used: (1) 5'UTR/Sig primer as described above and (2) a reverse primer D2AS 5'-GGGATTGGAGTTGTTACCTGTGAC-3' (nucleotides 445 ± 468). The RT procedure was performed using Random Hexamers (Perkin Elmer/Cetus, Norwalk, CT, USA) under the following conditions: RT at 428C for 15 min and inactivation of reverse transcriptase at 958C for 5 min. PCR was performed using a Perkin Elmer 2400 thermalcycler or an Ericomp TwinBlock 2 System Cycler as follows: (1) 948C for 1 min; (2) 35 cycles of 948C for 1 min, 608C for 1 min and 728C for 2 min; (3) 728C for 10 min. Alternatively the RT ± PCR was performed with the Titan 2 One Tube System (Boehringer Mannheim Biochemical, Indianapolis, IN, USA) according to the manufacturer's directions with the RT step done at 55 or 578C for 30 min followed by PCR conditions: (1) 948C for 2 min; (2) 10 cycles at 948C for 30 s, 608C for 30 s and 688C for 1.5 min; (3) 25 cycles at 948C for 30 s, 608C for 30 s and 688C for 1.5 min plus an additional 5 s each cycle; and (4) 688C for 7 min. Control templates for the PCR included 20 mg of pLNCX-7 and pLNCL DNA. No template negative controls were also run for each primer set. To visualize the PCR products, the samples were subjected to electrophoresis on 1.5% agarose gels containing ethidium bromide.
The 485 bp products of the 5'UTR/Sig+D2AS RT ± PCR were subjected to RE analysis with DraI, HincII and XbaI (New England Biolabs, Beverly, MA, USA) according to the directions of the manufacturer. Digested products were visualized on 2% agarose gels containing ethidium bromide.
Phenotypic analysis
IIF analysis of acetone-®xed frozen sections and acetone®xed cytospins prepared from suspensions of PC-3 cells using a Shandon Elliott Cytospin, was performed as described previously (Hixson et al., 1983 (Hixson et al., , 1985 . Fluorescein-conjugated, anity-puri®ed, goat anti-mouse IgG and goat antirabbit IgG were obtained from Sigma Chemical Company and Cappel/Organon Teknika, respectively. In order to better maintain the integrity of cell surface antigens, acetone-®xed sections and cytospins of cultured cells were post-®xed in 2% paraformaldehyde in PBS and then quenched twice for 2 min with 0.1 M glycine in PBS, pH 7.0 prior to staining with the anti-C-CAM (PAb 669) and anti-E-cadherin antibodies. The production and characterization of the monoclonal antibodies (MAbs) OV6 and DPI and the polyclonal antibody (PAb) 669 have been reported (Dunsford and Sell, 1989; Faris et al., 1991; Hixson et al., 1984; Lin and Guidotti, 1989; Mowery and Hixson, 1991) . OV6 is an MAb-de®ned epitope shared by cytokeratins 14 and 19 and Desmoplakin I (DPI) is the major plaque protein in desmosomal junctions. PAb 669 recognizes several uncharacterized epitopes on the two major isoforms of rat C-CAM, C-CAM1 and C-CAM2. PAb against E-cadherin was obtained from Sigma Chemical Company. MAbs 2. 25.3, 12.3.3 and 14.33.7 were raised in reconstituted SCID mice against primary human prostate carcinoma cells (A Makarovskiy, unpublished data). MAb 2.25.3 recognizes an epitope on basal cells of the human prostate and MAbs 12.3.3 and 14.33.7 recognize epitopes present on both basal and luminal cells of the human prostae (A Makarovskiy, unpublished data).
Ultrastructural, imaging and morphometric analysis
Tumor nodules ®xed in 2% paraformaldehyde and 0.1% gluteraldehyde in PBS were processed by standard methods and embedded in Spurr's medium as previously described (Mowery and Hixson, 1991) . 50 ± 80 nm thin sections were examined and photographed on a Philips 300 electron microscope (Philips Electronic Instruments, Inc, Mahwah, NJ, USA). 1 mM thick plastic sections were analysed at the light level for histyotypic organization and nuclear and nucleolar morphology. Eight to twelve images from dierent thick sections were captured with a 606 oil immersion objective with 26 video enlarger magni®cation using a Perceptives image acquisition program in the Central Research Laboratories, Rhode Island Hospital. These digitized images were then analysed using NIH Image version 1.6 to determine the area, perimeter, major axis and minor axis of nuclei and nucleoli. Data was collected from at least 140 nuclei for each of the PC-3 cell line derived tumors. Morphometric parameters including area to perimeter ratios and axial pro®le ratios (Williams, 1977) were calculated and plotted in frequency distribution graphs. Means and standard deviations (s.d.) of the raw data for area, perimeter, major axis and minor axis of both the nuclei and nucleoli were calculated using the Instat statistical program for MacIntosh. The Instat program was also used to compare the means and s.d. for area and perimeter of the C-CAM1 positive cell lines versus the C-CAM1 negative control cell line. Both an unpaired student t-test, which assumes Gaussian distribution and equal s.d., and an unpaired alternate Welch t-test, which assumes Gaussian distribution and unequal s.d. were used to calculate P values.
